All News

06:32pm Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month BU
03:42pm Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution EQ
12/02 Pharma companies left out of Trump's drug-pricing deals look for way in RE
12/02 Major U-turns on corporate splits in recent years RE
11/02 Pharma companies left out of Trump's drug-pricing deals look for way in RE
11/02 Major U-turns on corporate splits over the years RE
11/02 Major U-turns on corporate splits in recent years RE
11/02 Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution EQ
11/02 Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution EQ
11/02 German drugmakers lobby says US price rules will challenge domestic market RE
11/02 German drugmakers lobby says US price rules will challenge domestic market RE
09/02 BAYER AG : Goldman Sachs reiterates its Buy rating ZD
07/02 Bayer Cleared to Offer Stryax After EPA Registers Dicamba Herbicides DJ
06/02 BAYER AG : Gets a Buy rating from Barclays ZD
06/02 Bayer Hesitates to Raise Sales Forecast Despite Asundexian Breakthrough RE
06/02 Bayer Aktiengesellschaft - Special Call
06/02 Bayer confident in asundexian but too early to comment on specific peak sales numbers RE
06/02 Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution EQ
06/02 Bayer Kept at Buy as BofA Notes Positive Late-stage Data for Stroke Prevention Drug MT
06/02 Markets Ask the Obvious Question Zonebourse
06/02 Diary - Europe's STOXX 600 Corporate Earnings Week Ahead RE
06/02 Frankfurt Stocks Opening: AI Concerns Unsettle Investors - Auto Shares Weak DP
06/02 JPMorgan Maintains 'Overweight' Rating on Bayer DP
06/02 BAYER AG : UBS reaffirms its Neutral rating ZD
06/02 UBS Maintains 'Neutral' Rating on Bayer, Target Price at 32 Euros DP
No results for this search